LYEL
Lyell Immunopharma, Inc.
NASDAQ · USHealthcareBiotechnology
$12.92-3.00%
Price as of Jul 20, 2026
LYEL valuation
Lyell Immunopharma, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.10x
- Price / sales
- 9725.05x
- Price / cash flow
- -2.25x
Enterprise value
- Enterprise value
- $96.3M
- EV / sales
- 3106.59x
- EV / EBITDA
- -0.40x
- EV / EBIT
- -0.50x
- Market cap
- $301.5M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.